DiaMedica Therapeutics Inc.
DMACDiaMedica reported a net loss of $32.8M in FY2025, a 34% increase from the prior year, driven by expanded clinical development activities, with free cash flow usage rising to $29.1M.
NASDAQ
Healthcare
Biotechnology
$6.47
+0.05(0.8%)
52W $3.38 – $9.39
Quick:
8-K
Mar 30, 2026 (1 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Mar 30, 2026 (1 weeks ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Feb 6, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jan 5, 2026 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 18, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Nov 12, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 12, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13G/A
Nov 7, 2025 (5 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Oct 15, 2025 (5 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Sep 4, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G
Aug 27, 2025 (7 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Aug 12, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 12, 2025 (7 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Aug 12, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 6, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Jul 30, 2025 (8 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Jul 30, 2025 (8 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jul 21, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction